AIM Biotech
PrivateLast Round
Grant
Aug 20, 2021
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AIM Biotech is a biotechnology company that develops and provides organ-on-a-chip systems, also known as 3D cell culture platforms, for use in medical research, drug discovery, and clinical investigation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIM Biotech Comparables
Compare AIM Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beonchip | 89% | |
| AlveoliX AG | 88% | |
| Akita | 86% |
AIM Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 20, 2021 | ||||
| Series A | Nov 19, 2020 | ||||
| Seed | Sep 4, 2016 |
AIM Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Series A |
| Black Kite Capital | Series A |
| Wavemaker Three-Sixty Health | Series A |
| Wavemaker Ventures | Series A |
| Venturecraft | Series A, Seed |
| SMART Innovation Centre | Grant |
| Elev8.vc | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 31% MoM, reaching 4.3K.
- Apr 15, 2026
Monthly visitors increased 82% MoM.
AIM Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AIM Biotech's valuation, stock price, and market status.
Is AIM Biotech a public or private company?
AIM Biotech is a private company.
What is the current stock price of AIM Biotech?
AIM Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is AIM Biotech worth (valuation)?
Valuation information for AIM Biotech is not publicly available.
Can I buy AIM Biotech stock?
AIM Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AIM Biotech's last funding round?
AIM Biotech's most recent funding round was Grant on August 20, 2021.
Who are the main investors in AIM Biotech?
Key investors in AIM Biotech include Wavemaker Ventures.
Will AIM Biotech IPO soon?
No public IPO plans have been announced for AIM Biotech.
How can I track AIM Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AIM Biotech's secondary market activity and sign up for updates.